-
公开(公告)号:US09938316B2
公开(公告)日:2018-04-10
申请号:US14913366
申请日:2014-08-27
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Steven J. D. Karlish , Adriana Katz , Daniel M. Tal , Arie Marcovich
CPC classification number: C07J43/003 , C07J19/005
Abstract: The present invention relates to digoxin and digitoxin derivatives that are selective inhibitors of the α2 isoform of Na,K-ATPase, and that reduce intra-ocular pressure. The invention further relates to uses of these derivatives for treating disorders associated with elevated intraocular pressure, such as glaucomas, and/or as cardiotonic agents.
-
2.
公开(公告)号:US10668094B2
公开(公告)日:2020-06-02
申请号:US15745441
申请日:2016-07-19
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Steven J. D. Karlish , Adriana Katz , Daniel M. Tal , Arie Marcovich
Abstract: Provided herein are alpha2-selective Na,K-ATPase inhibitors and prodrugs thereof, characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative, as well as uses thereof in lowering intraocular pressure and in treating glaucoma and heart conditions.
-
公开(公告)号:US11077128B2
公开(公告)日:2021-08-03
申请号:US16847737
申请日:2020-04-14
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Steven J. D. Karlish , Adriana Katz , Daniel M. Tal , Arie Marcovich
Abstract: Provided herein are alpha2-selective Na,K-ATPase inhibitors and prodrugs thereof, characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative, as well as uses thereof in lowering intraocular pressure and in treating glaucoma and heart conditions.
-
-